+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
Fibromyalgia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Fibromyalgia Therapeutics - Global Strategic Business Report

  • Report
  • March 2026
  • 263 Pages
  • Global
From
Endometriosis Drugs - Global Strategic Business Report - Product Thumbnail Image

Endometriosis Drugs - Global Strategic Business Report

  • Report
  • March 2026
  • 191 Pages
  • Global
From
Glucosamine - Global Strategic Business Report - Product Thumbnail Image

Glucosamine - Global Strategic Business Report

  • Report
  • March 2026
  • 167 Pages
  • Global
From
From
Glucosamine Gummies Market - Global Forecast to 2030 - Product Thumbnail Image

Glucosamine Gummies Market - Global Forecast to 2030

  • Report
  • August 2025
  • 197 Pages
  • Global
From
Systemic Lupus Erythematosus Market - Global Forecast 2026-2032 - Product Thumbnail Image

Systemic Lupus Erythematosus Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Ocular Immunosuppressants Market - Global Forecast 2026-2032 - Product Thumbnail Image

Ocular Immunosuppressants Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Lodine Tincture Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lodine Tincture Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 183 Pages
  • Global
From
Gout Therapeutics Market Report 2026 - Product Thumbnail Image

Gout Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Celiac Disease Treatment Market Report 2026 - Product Thumbnail Image

Celiac Disease Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Corticosteroids Market Report 2026 - Product Thumbnail Image

Corticosteroids Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Crohn's Disease Treatment Market Report 2026 - Product Thumbnail Image

Crohn's Disease Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market Report 2026 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Crohn's Disease (CD) Treatment Market Report 2026 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Lupus Therapeutics Market Report 2026 - Product Thumbnail Image

Lupus Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Non-Steroidal Anti-inflammatory Drugs Market Report 2026 - Product Thumbnail Image

Non-Steroidal Anti-inflammatory Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Axial Spondyloarthritis (axSpA) Market Report 2026 - Product Thumbnail Image

Axial Spondyloarthritis (axSpA) Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Aspirin Market Report 2026 - Product Thumbnail Image

Aspirin Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more